News of the expansion comes in tandem with Cenduit’s recent appointment of Chris Dailey as global head of technology. Dailey joins Cenduit with more than 15 years of interactive, software and telecommunications experience. In his role as global head of technology, Dailey will lead cutting-edge technology and service initiatives aimed at providing additional system functionality as well as improving the user experience for those interfacing with Cenduit Interactive Response Technology (IRT) to conduct clinical trials at sites across the globe.
“The expansion and the acquisition of senior leadership like Chris give us the bandwidth to execute our plans to implement new technologies and augment the breadth of services that we provide to sponsors,” said Desai. “Our top priority is enabling investigator sites to achieve overall compliance through seamless management of patient enrollment and treatment throughout the clinical trial.”
About Cenduit LLC
Cenduit provides interactive response technology (IRT) - driven services for clinical trials around the world. Cenduit’s IRT solutions deliver optimized clinical supply chain management and facilitate precise control over patient randomization and drug administration to enable more efficient, compliant trials. With expert personnel located around the globe, Cenduit’s unprecedented level of support currently covers more than 16,000 sites in more than 100 countries. Focus on trials, not tribulations, with Cenduit. For more information or to connect with Cenduit, visit www.cenduit.com.
